Fabian D. F.Uebele

Associate

Frankfurt + 49.69.9726.3925

Connect:

Share

Fabian Uebele joined our New Lawyers Group (NLG) in 2020. The NLG provides our newest lawyers with the opportunity to gain exposure to different practice areas and lawyering styles before making a commitment to a specific practice. Individuals in the NLG may focus on a particular area of practice, or compare practices, during their first year with Jones Day. Fabian will be focusing on antitrust and competition law.

Fabian worked at an international law firm and in the legal department at one of the largest chemical producers in the world during his clerkship. Prior to joining Jones Day, he was a research associate for the competition law program at the University of Mannheim, and he continues to serve as a lecturer for competition law at the university

Experience

  • Cleveland-Cliffs acquires ArcelorMittal USA for approximately $1.4 billionJones Day advised Cleveland-Cliffs Inc. in connection with the acquisition and financing of substantially all of the operations of ArcelorMittal USA for approximately $1.4 billion.
  • Astellas transfers DIFICLIR in Europe, Middle East, Africa, and selected CIS to Swiss Tillotts Pharma AG for €109 millionJones Day advised Astellas Pharma Europe Ltd. on the sale of distribution rights to the product "DIFICLIR" in Europe, Middle East, Africa, and selected Commonwealth of Independent States (CIS) countries to Swiss Tillotts Pharma AG for €109 million.
  • Solvay to sell barium, strontium and sodium percarbonate businesses to Latour CapitalJones Day is advising Solvay S.A., a publicly listed chemical company based in Brussels, Belgium, on the combined sale of its technical-grade barium and strontium business in Germany, Spain and Mexico, and its sodium percarbonate business in Germany to Latour Capital.
  • STERIS acquires Key Surgical for approximately $850 millionJones Day advised STERIS plc (NYSE: STE) in the $850 million acquisition of Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products, and a portfolio company of Water Street Healthcare Partners, LLC.
  • Valmet acquires stake in Neles from SolidiumJones Day served as antitrust counsel to Valmet Oyj in its acquisition of stake in Neles Corporation from Solidium Oy.
    • View All

    January 2021 Commentaries

    Germany Adopts New Competition Rules for Tech Platforms

    January 2021 Reprints

    WRP 2021, 11

    September 2020 Reprints

    Kommentar zu BGH: App-Zentrum

    Additional Publications

    • 2021
      Die Grenzen der Durchsetzung eines europäisierten Datenschutzrechts. Verbandsklagen bei Verstößen gegen das Datenschutzrecht, Wettbewerb in Recht und Praxis 2021, 11-15
    • 2020
      Anmerkung zu BGH, Beschl. v. 28.05.2020, Az. I ZR 186/17 (App-Zentrum), Wettbewerb in Recht und Praxis 2020, 1187-1189
    • 2019
      Datenschutzrecht vor Zivilgerichten. Die Durchsetzung des Datenschutzrechts über UWG und UKlaG auf dem Prüfstand von Rechtsprechung und Gesetzgeber, Gewerblicher Rechtsschutz und Urheberrecht 2019, 694-703
    • 2018
      Anwalt des Verbrauchers, Freund des Gerichts. Verbraucherschutzrechtliche Sektoruntersuchungen, Neue Zeitschrift für Kartellrecht 2018, 459-464
    • 2018
      Das "Unternehmen" im europäischen Datenschutzrecht, Europäische Zeitschrift für Wirtschaftsrecht 2018, 440-446
    • 2018
      Die "goldene Brücke" zum Verbraucherschutz. Abmahnungen nach verbraucherschutzrechtlichen Sektoruntersuchungen, Neue Zeitschrift für Kartellrecht 2018, 521-524
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.